SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott launches COVID-19 home test kit in India

12 Jul 2021 Evaluate

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India Share Price

26073.95 -404.65 (-1.53%)
11-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1275.05
Cipla 1383.00
Zydus Lifesciences 1105.65
Lupin 2274.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: